Market Place
Market Place
Post Enquiry
FDA Warning Letter To India`s Zydus Flags Glass Contamination Concerns
12 Sep 2024 //
ENDPTS
FDA Warns Two Chinese Firms Over Data And Lab Practice Violations
11 Sep 2024 //
PR NEWSWIRE
DCGI suspends nod to Entod`s new eye drops over unapproved `claims`
11 Sep 2024 //
ECONOMICTIMES
Fake Ozempic: Batch Numbers Help Spread Dangerous Weight Loss Drugs
05 Sep 2024 //
REUTERS
Lupin, Dr Reddy`s recall products in US due to manufacturing issues
04 Sep 2024 //
BUSINESS STANDARD
Dr. Reddy`s banned from China`s drug procurement program after inspectors
03 Sep 2024 //
FIERCE PHARMA
CDSCO reports low failure rate in cough syrup testing enhanced supply monitoring
02 Sep 2024 //
EXPRESSPHARMA
CARsgen Warning Letter Notes Company Paused Manufacture Following 483
30 Aug 2024 //
FDANEWS
Zydus Lifesciences Gets Warning Letter From USFDA For Jarod Injectable Unit
30 Aug 2024 //
ECONOMICTIMES
Global Calcium Receives FDA Form 483 After Plant Inspection
29 Aug 2024 //
FIERCE PHARMA
EyePoint Receives FDA Warning Letter For Eye Implant Manufacturing Issues
28 Aug 2024 //
FIERCE PHARMA
Infant Formula Recall Update as FDA Issues Concern Level
27 Aug 2024 //
NEWSWEEK
Aurobindo, Glenmark, FDC Recall US Products Over Manufacturing Issues
26 Aug 2024 //
ECONOMICTIMES
U.S. FDA issues observations to Dr. Reddy’s unit in Srikakulam
26 Aug 2024 //
THEHINDU
US FDA classifies recall of Inari`s catheter devices as `most serious`
24 Aug 2024 //
REUTERS
FDC`s Baddi unit passes US FDA inspection with Zero 483 observations
23 Aug 2024 //
CNBCTV
Indonesia court finds drugmakers at fault over toxic cough syrup, awards parents
23 Aug 2024 //
REUTERS
Govt bans 156 fixed-dose combo drugs over risks
22 Aug 2024 //
ECONOMICTIMES
US FDA declines to approve Regeneron`s blood cancer therapy
21 Aug 2024 //
REUTERS
United Health Products Submits Response Letter to FDA
19 Aug 2024 //
GLOBENEWSWIRE
FDA Warns Clinical Investigator And Device Firm For Violations
16 Aug 2024 //
RAPS
Aurobindo Pharma`s Eugia Unit-3 gets warning letter from USFDA, shares fall
16 Aug 2024 //
ECONOMICTIMES
B. Braun, Baxter Recall Products Over Quality Concerns
16 Aug 2024 //
FIERCE PHARMA
FDA Warns Austrofood, Monitors U.S. Cinnamon Product Safety
15 Aug 2024 //
PR NEWSWIRE
USFDA observations for Biocon Biologics unit. Details here
08 Aug 2024 //
CNBCTV18
Perrigo recalls 16,500 cans of its infant formula
08 Aug 2024 //
REUTERS
FDA blasts Bristol Myers over misleading Krazati efficacy claims
08 Aug 2024 //
FIERCE PHARMA
Medtronic recalls nerve monitoring tech linked to 10 patient injuries
08 Aug 2024 //
FIERCE BIOTECH
FDA Issues `Official Action Indicated` For Aurobindo`s Eugia Unit
06 Aug 2024 //
BSEINDIA
Indian Drug Controllers Recall Highest Number Of Batches In FY23-24
05 Aug 2024 //
PHARMABIZ
U.S. FDA issues 3 observations to Gland Pharma facility in Hyderabad
02 Aug 2024 //
THEHINDU
FDA Warns Retailers Over Unapproved Skin Peel Products
30 Jul 2024 //
RAPS
Compounded Injectable Semaglutide Dosing Errors Cause Adverse Events
29 Jul 2024 //
CONTRACT PHARMA
USFDA completes inspection at Biocon Biologics’ facilities in Bengaluru
29 Jul 2024 //
INDIANPHARMAPOST
CHMP has adopted a negative opinion on lecanemab for the EU
26 Jul 2024 //
PR NEWSWIRE
Gland Pharma Shares Slip 2% as USFDA Issued 2 Observations
25 Jul 2024 //
THEHINDU
Brassica hit with warning letter after employees faked data results
24 Jul 2024 //
ENDPTS
India Considers Dropping Quality Tests For Cough Syrups From Approved Plants
23 Jul 2024 //
BUSINESS STANDARD
Hikma Extends Pain Drug Recall Due To Potential Sedative Presence
23 Jul 2024 //
FIERCE PHARMA
Allarity warned of pending SEC enforcement action over FDA meeting conduct
22 Jul 2024 //
FIERCE BIOTECH
Investors dump Korean biotech HLB stocks on FDA rejection
21 Jul 2024 //
KEDGLOBAL
Sanofi Reports Total Voting Rights And Shares For June 2024
21 Jul 2024 //
LIVEMINT
U.S. FDA Inspects Divi`s Labs Facility In Visakhapatnam
19 Jul 2024 //
NDTV PROFIT
Daewoong Bio Banned From China Drug Program After Refusing Inspection
19 Jul 2024 //
FIERCE PHARMA
US FDA declines to approve Orexo`s opioid overdose drug
17 Jul 2024 //
REUTERS
Inside the FDA concerns that sank Hengrui`s PD-1 drug filing
16 Jul 2024 //
FIERCE PHARMA
Unichem gets 5 observations from USFDA for Goa formulation facility
16 Jul 2024 //
INDIANPHARMAPOST
Endo USA Recalls Mislabeled Clonazepam Tablets Lot 550147301
16 Jul 2024 //
PRESS RELEASE
Suven gets Form 483 from with two observations from USFDA for Casper Pharma
14 Jul 2024 //
INDIANPHARMAPOST
Immutep’s LAG-3 drug scores in Phase 2b head and neck cancer test
13 Jul 2024 //
PRESS RELEASE
Lilly says lupus drug dropped from pipeline failed to show efficacy
13 Jul 2024 //
ENDPTS
Lupin receives EIR from USFDA for its Dabhasa facility
13 Jul 2024 //
INDIANPHARMAPOST
Novo Nordisk`s Ozempic cuts dementia risk vs. Merck`s Januvia
12 Jul 2024 //
FIERCE PHARMA
Kazia prunes failed cancer trial data set to form path to FDA
11 Jul 2024 //
PR NEWSWIRE
Novo Nordisk Receives Complete Response Letter For Weekly Insulin Icodec
10 Jul 2024 //
GLOBENEWSWIRE
Shilpa Pharma Unit 2 Raichur Clears ANVISA-Brazil GMP Inspection
10 Jul 2024 //
INDIANPHARMAPOST
FDA recalls Inspire Medical`s sleep apnea nerve stimulator recall
09 Jul 2024 //
FIERCE BIOTECH
Dr Reddy`s, Sun Pharma recall drugs in US market: USFDA
04 Jul 2024 //
ECONOMIC TIMES
Roche sues Stanford, Foresight Diagnostics over trade secrets
04 Jul 2024 //
FIERCE PHARMA
USFDA pulls up Sun Pharma for manufacturing issues at Dadra facility
03 Jul 2024 //
ECONOMICTIMES
